This age-related pattern is consistent with findings from Tridgell et al., who analyzed 5020 subjects from the T1DM Genetic Database and reported a higher prevalence of anti-GAD antibodies in individuals diagnosed after the age of 13 [23]. This evidence concerns the gene GAD1 and type 1 diabetes mellitus.